4 Αποτελέσματα
BACKGROUND OF THE INVENTION
The present invention is directed to prodrug esters of phenolic 2-piperidino-1-alkanols, as depicted by the formulas (I) and (II), below; to pharmaceutical compositions thereof; to a method of treating stroke, traumatic head injury, or a CNS degenerative disease
BACKGROUND OF THE INVENTION
The present invention is directed to neuroprotective (antiischemic and excitory aminoacid receptor blocking) 2-piperidino-1-alkanol derivatives defined by the formula (I) below; pharmaceutically acceptable salts thereof; a method of using these compounds in the treatment
FIELD OF THE INVENTION
The present invention relates to alkanoyl and cycloalkanoyl-amine derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS),
BACKGROUND OF THE INVENTION
The present invention is directed to neuroprotective (antiischemic and excitatory aminoacid receptor blocking) phenol derivatives defined by the formula (I) below; pharmaceutically acceptable salts thereof; pharmaceutical compositions thereof; a method of using these